Multiple Sclerosis, Iyenagar Yoga, Yoga, EDSSNCT05247372

The Effect of Iyengar Yoga Practice on Patients with Multiple Sclerosis

A study testing The effect of Iyengar yoga practice on patients with multiple sclerosis in people with Multiple Sclerosis, Iyenagar Yoga, Yoga, EDSS, run by University Hospital, Motol at 1 site in Czechia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

The aim of this work is to find out what effect the practice of Iyengar yoga has on patients with multiple sclerosis on the EDSS 5 and more, specifically in the field of mobility, self-sufficiency and anxiety. Read more about this study

Who is it for?: Ages 18 years and older, women only
Conditions the study is for: Multiple Sclerosis, Iyenagar Yoga, Yoga, EDSS
What is being tested?: The effect of Iyengar yoga practice on patients with multiple sclerosis
Could I receive a placebo?: No, everyone receives an active treatment
How many people: 5 participants
Where: 1 siteCzechia
Study dates: 25 Jun 2021to 30 Jun 2022
Phase: Interventional
Are there results?: None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 years and older
Women only
No healthy volunteers
Adult, Older adult

Who may be able to join

age over 18 years
diagnosis of multiple sclerosis
EDSS grade 5 or higher

Who cannot join

age less than 18 years
the patient is not diagnosed with multiple sclerosis EDSS grade less than 5
refusal of the subject to participate in the study

Trial locations and contacts

1 site in 1 country.

Czechia1 site

University Hospital Motol
Prague, Czech Republic, 15006

Other trials in Czechia

About this study

Conditions: Multiple Sclerosis, Iyenagar Yoga, Yoga, EDSS
Being tested: The effect of Iyengar yoga practice on patients with multiple sclerosis
Medical subject headings: Multiple Sclerosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

The effect of Iyengar yoga practice on patients with multiple sclerosisOther
The study will be conducted as a longitudinal follow-up - at first patients will fbe examined 2 months before the start of the exercise, than they will be examined at the beginning and end of the exercise, which they will attend for 3 months. Patients will be re-examined 2 months after the end of the exercise to clarify the continuing effect of the exercise. The examination will include a basic kinesiological analysis and a neurological examination,TUG test, 6MWT along with the Borg Subjective Weight Rating Scale and T25FWT, BBS, NHPT and stable sitting time in wheelchairs. To evaluate the development of the chest, the respiratory amplitude will be examined and the position of the spine in statics and dynamics will be evaluated using a spinal mouse. Quality of life will be assessed through the MFIS, MSIS-29, MSQOL 54 questionares and Beck's anxiety inventory.

Study groups in NCT05247372
Study group	Role	What they receive
The effect of Iyengar yoga practice on patients with multiple sclerosis	Other	Not described Receives: Other: The effect of Iyengar yoga practice on patients with multiple sclerosis

What is being measured

The primary outcome is the main question the study is designed to answer.

Hypothesis 1
Increase in respiratory amplitud. It will be measured by the meter.
Measured: 3 months
Hypothesis 2
Increase in spinal development in the sagittal and frontal plane. It will by measured by spinal mouse.
Measured: 3 months
Hypothesis 3
Increase in walking speed measured by T25FWT. It will by measured by stopwatch.
Measured: 3 months
Hypothesis 4
Balance improvement in the Berg balance scale. It will be measured by the Berg balance scale questionare.
Measured: 3 months
Hypothesis 5
The quality of life of patients with MS is improved subjectively evaluated through MSQOL54 questionare.
Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

25 Jun 202130 Jun 2022

First posted18 Feb 2022
Study start25 Jun 2021
Primary completion30 Jun 2022
Study completion30 Jun 2022

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Other trials for Multiple Sclerosis, Iyenagar Yoga, Yoga, EDSSStudies of the same condition, open and under way.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase N/A
Primary purpose: Treatment
Allocation: Not applicable
Intervention model: Single group
Masking: None (open label)
Enrolment: 5 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT05247372
Sponsor's protocol ID: EK-809/21
Status last verified: Sep 2024
First submitted: 3 Jan 2022
Last updated: 19 Sep 2024
Results posted: No
Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No
Individual data sharing: Yes

Study at a glance

From the registry record, last updated by the sponsor on 19 Sep 2024. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: The Effect of Iyengar Yoga Practice on Patients with Multiple Sclerosis
ClinicalTrials.gov ID: NCT05247372
Acronym / sponsor ID: EK-809/21
Conditions: Multiple Sclerosis, Iyenagar Yoga, Yoga, EDSS
Study type: Interventional
Recruitment status: Completed
Enrolment: 5 participants (actual)
Lead sponsor: University Hospital, MotolUniversity, hospital or other
Study start: 25 Jun 2021 (actual)
Primary completion: 30 Jun 2022 (actual)
Study completion: 30 Jun 2022 (actual)
First posted: 18 Feb 2022 (actual)
Results: Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

Study design

Primary purpose: Treatment
Allocation: Not applicable
Intervention model: Single group
Masking: None (open label)
Number of arms: 1

Arm	Type	Receives
The effect of Iyengar yoga practice on patients with multiple sclerosis	Other	Other: The effect of Iyengar yoga practice on patients with multiple sclerosis

Who may qualify

Ages: 18 years and older
Sex: Female only
Healthy volunteers: Not accepted
Age groups: Adult, Older adult

Key inclusion criteria (3 listed)

age over 18 years
diagnosis of multiple sclerosis
EDSS grade 5 or higher

Key exclusion criteria (3 listed)

age less than 18 years
the patient is not diagnosed with multiple sclerosis EDSS grade less than 5
refusal of the subject to participate in the study

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Intervention	Type	Arms
The effect of Iyengar yoga practice on patients with multiple sclerosisThe study will be conducted as a longitudinal follow-up - at first patients will fbe examined 2 months before the start of the exercise, than they will be examined at the beginning and end of the exercise, which they will attend for 3 months. Patients will be re-examined 2 months after the end of the exercise to clarify the continuing effect of the exercise. The examination will include a basic kinesiological analysis and a neurological examination,TUG test, 6MWT along with the Borg Subjective Weight Rating Scale and T25FWT, BBS, NHPT and stable sitting time in wheelchairs. To evaluate the development of the chest, the respiratory amplitude will be examined and the position of the spine in statics and dynamics will be evaluated using a spinal mouse. Quality of life will be assessed through the MFIS, MSIS-29, MSQOL 54 questionares and Beck's anxiety inventory.	Other	The effect of Iyengar yoga practice on patients with multiple sclerosis

Primary outcome

Hypothesis 1
Time frame: 3 months
Increase in respiratory amplitud. It will be measured by the meter.
Hypothesis 2
Time frame: 3 months
Increase in spinal development in the sagittal and frontal plane. It will by measured by spinal mouse.
Hypothesis 3
Time frame: 3 months
Increase in walking speed measured by T25FWT. It will by measured by stopwatch.
Hypothesis 4
Time frame: 3 months
Balance improvement in the Berg balance scale. It will be measured by the Berg balance scale questionare.
Hypothesis 5
Time frame: 3 months
The quality of life of patients with MS is improved subjectively evaluated through MSQOL54 questionare.

Results and safety

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 19 Sep 2024.
Individual participant dataSharing planned: Yes

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

The record lists no contact. Use the official record to reach the sponsor.

1 site in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hypothesis 1 (time frame: 3 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05247372.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024; AzTrials last refreshed its copy on 6 Nov 2026.